Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
Other Equity
Aurinia Pharmaceuticals Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Equity
-$854k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
43%
|
|
Zymeworks Inc
NYSE:ZYME
|
Other Equity
-$6.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Other Equity
$744k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
14%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Equity
$28k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Equity
$237k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Other Equity
CA$10.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
See Also
What is Aurinia Pharmaceuticals Inc's Other Equity?
Other Equity
-854k
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Other Equity amounts to -854k USD.
What is Aurinia Pharmaceuticals Inc's Other Equity growth rate?
Other Equity CAGR 10Y
43%
Over the last year, the Other Equity growth was 15%. The average annual Other Equity growth rates for Aurinia Pharmaceuticals Inc have been -2% over the past three years , -1% over the past five years , and 43% over the past ten years .